ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome
Hormone replacement therapy also tied to elevated gastrointestinal symptoms and diagnostic testing
Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
Rosuvastatin tied to cardiovascular and mortality benefits but also higher risk for type 2 diabetes
Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
cf-bDNA costs $89,600 per quality-adjusted life year gained, with alternatives less costly and more effective
Causal Relationship Seen Between GERD and Hypertension
Authors call for future research to examine implications of GERD detection, management for the prevention and treatment of hypertension
Restaging MRI Can Predict Survival With Rectal Cancer
Findings can save some lower-risk patients surgery after chemo, radiation
ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With Rifaximin
Rifaximin monotherapy reduces risk for breakthrough OHE episode and results in a lower mortality rate than lactulose monotherapy
Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
Recellularization via electroporation therapy found to be feasible and safe
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
Vyloy is the first and only CLDN18.2-targeted therapy approved in the United States
FDA Appoints New Head of Medical Devices
Computer-Aided Detection Colonoscopies Tied to Improved Adenoma Detection Rate
Similar average advanced colorectal neoplasia per colonoscopy seen with CADe-enhanced and conventional colonoscopy
